Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast


Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Database Update: API Import to Russia (December 2017)

Friday, February 16, 2018

Between January and December 2017, Russia imported 74 bln RUB worth of APIs (free circulation prices plus VAT). Pharmacopoeial APIs take up most of it (97.5%) and contributed to the total import volume in monetary terms, which has risen by 22% in comparison with the same period in 2016. Pharmacopoeial API import has risen by 23% over the year, and imports of technical raw materials have decreased by 5.5%.

API import volumes in monetary terms have also risen by 6% since 2016. However, the rate of import of pharmacopoeial API raw materials is way behind that of technical APIs (+5.2% and +26.3%, respectively). In 2017, Russia imported around 12.4 tons of APIs.

China is still the main supplier of APIs to Russia. Chinese imports lead the way both in monetary and physical terms, with a 19.3% and almost 68% share in monetary and physical terms, respectively, since 2017. In 2017, Russia imported 278 different API names (according to INN) from China. In monetary terms, API import from China has fallen by 6%.

Argentina made the best progress in monetary terms; API import to Russia from Argentina has increased by 9.4 times. Despite that, its share in the total volume of imports is 0.2%. In 2017, Russia imported only 2 API names from Argentina. Glatiramer acetate, which was imported by R-Pharm for production of Glatirat, had the biggest share.

Dynamics of API import to Russia (RUB, including VAT) (January 2016 – December 2017)